143 related articles for article (PubMed ID: 15974880)
1. Telomere maintenance and tumorigenesis: an "ALT"ernative road.
Stewart SA
Curr Mol Med; 2005 Mar; 5(2):253-7. PubMed ID: 15974880
[TBL] [Abstract][Full Text] [Related]
2. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection?
Nittis T; Guittat L; Stewart SA
Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells.
Liu H; Xu C; Diplas BH; Brown A; Strickland LM; Yao H; Ling J; McLendon RE; Keir ST; Ashley DM; He Y; Waitkus MS
Neuro Oncol; 2023 Sep; 25(9):1563-1575. PubMed ID: 36689342
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of telomerase induces alternative lengthening of telomeres during human esophageal carcinogenesis.
Queisser A; Heeg S; Thaler M; von Werder A; Opitz OG
Cancer Genet; 2013 Nov; 206(11):374-86. PubMed ID: 24331919
[TBL] [Abstract][Full Text] [Related]
5. Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof.
Claude E; Decottignies A
Curr Opin Genet Dev; 2020 Feb; 60():1-8. PubMed ID: 32114293
[TBL] [Abstract][Full Text] [Related]
6. Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).
De Vitis M; Berardinelli F; Sgura A
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463031
[TBL] [Abstract][Full Text] [Related]
7. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.
Stewart SA; Hahn WC; O'Connor BF; Banner EN; Lundberg AS; Modha P; Mizuno H; Brooks MW; Fleming M; Zimonjic DB; Popescu NC; Weinberg RA
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12606-11. PubMed ID: 12193655
[TBL] [Abstract][Full Text] [Related]
8. Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.
Gocha ARS; Harris J; Groden J
Mutat Res; 2013; 743-744():142-150. PubMed ID: 23219603
[TBL] [Abstract][Full Text] [Related]
9. Long telomeres bypass the requirement for telomere maintenance in human tumorigenesis.
Taboski MA; Sealey DC; Dorrens J; Tayade C; Betts DH; Harrington L
Cell Rep; 2012 Feb; 1(2):91-8. PubMed ID: 22832159
[TBL] [Abstract][Full Text] [Related]
10. Alternative lengthening of telomeres in human cells.
Reddel RR; Bryan TM; Colgin LM; Perrem KT; Yeager TR
Radiat Res; 2001 Jan; 155(1 Pt 2):194-200. PubMed ID: 11121234
[TBL] [Abstract][Full Text] [Related]
11. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
Sun B; Chen M; Hawks CL; Hornsby PJ
Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
[TBL] [Abstract][Full Text] [Related]
12. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.
Grobelny JV; Kulp-McEliece M; Broccoli D
Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
Pompili L; Leonetti C; Biroccio A; Salvati E
J Exp Clin Cancer Res; 2017 Dec; 36(1):189. PubMed ID: 29273061
[TBL] [Abstract][Full Text] [Related]
15. Telomere maintenance in sarcomas.
Johnson JE; Broccoli D
Curr Opin Oncol; 2007 Jul; 19(4):377-82. PubMed ID: 17545803
[TBL] [Abstract][Full Text] [Related]
16. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
17. Super-telomeres in transformed human fibroblasts.
Chiodi I; Belgiovine C; Zongaro S; Ricotti R; Horard B; Lossani A; Focher F; Gilson E; Giulotto E; Mondello C
Biochim Biophys Acta; 2013 Aug; 1833(8):1885-93. PubMed ID: 23570868
[TBL] [Abstract][Full Text] [Related]
18. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
[TBL] [Abstract][Full Text] [Related]
19. Telomerase is frequently activated in tumors with microsatellite instability.
Ibanez de Caceres I; Frolova N; Varkonyi RJ; Dulaimi E; Meropol NJ; Broccoli D; Cairns P
Cancer Biol Ther; 2004 Mar; 3(3):289-92. PubMed ID: 14726659
[TBL] [Abstract][Full Text] [Related]
20. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.
Counter CM; Hahn WC; Wei W; Caddle SD; Beijersbergen RL; Lansdorp PM; Sedivy JM; Weinberg RA
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14723-8. PubMed ID: 9843956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]